Project Details
Abstract
There are four major topics of pharmacoeconomic and market researches on brand name and
generic drugs in this study: first, adopting a second new drug into the medical market;
second, brand-switching after the price regulation; third, the variation of generic drug among
medical care institutes; forth, drug wastage in expenditures on drugs. To do this, we plan to
select one new drug, Thiazolidinediones (TZD), as our study case for our four-year series of
study: (1). use GEE linear regression to examine the penetration of a new drug; (2). use GEE
logistic regression to examine the brand switching after price regulation; (3). use
concentration curve and index, and its decomposition to examine the distribution of the
generics drugs among medical care institutes; (4). use decision-analytic modeling to examine
the drug expenditures due to drug wastage. Our research findings are expected to provide
valuable information on the influence of new drug, price regulation, generic drugs and drug
wastage on market behavior and medical expenditure
Project IDs
Project ID:PF10107-1983
External Project ID:NSC101-2410-H182-023
External Project ID:NSC101-2410-H182-023
| Status | Finished |
|---|---|
| Effective start/end date | 01/08/12 → 31/07/13 |
Keywords
- new drugs
- price regulation
- generic drugs
- drug wastage
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.